Through a series of strategic acquisitions,CR Sanjiu successfully expanded into antifungal, antitumor and anti-infection treatments.In 2023, CR Sanjiu achieved revenues of 24.74 billion yuan,with 39 ...
诱导嵌合抗原受体表达的CNS靶向T细胞有效清除了原发性和继发性脑肿瘤 ... Abstract: The true state of ocean biodiversity is difficult to assess, and there are few global indicators to track the primary threat of overfishing. We ...